WinstonWınston
Back
Stock

Henry Schein

HSIC
53
Medical - Distribution · Healthcare
Also trades as: 0L3C.L GBP 0.86 (+1.41%)
Price
$86.00
+0.99 (+1.16%)
Market Cap
$9.58B
Exchange
NASDAQ
Winston Score
53
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Oct 23, 2026 · filings through Jun 27, 2026

§How the score breaks down

Quality
Mixed
9/30
Growth
Good
12/20
Cash Flow
Strong
7/10
Stability
Good
5/10
Valuation
Strong
7/10
Ownership
Good
10/15
Dividends
Not counted
n/a

50 of 95 counted points = Winston Score 53. Pillars marked n/a do not apply to this company and are left out of the total.

Track this stock — start free trial

Share count falling — buybacks

−14.1% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 141.8M (2021) → 121.7M (2025)

§Winston Score History

The full picture

Henry Schein is a distributor of healthcare products and services, mainly selling dental and medical supplies to private practice offices, clinics, and hospitals. Its customers are mostly dentists, physicians, and other healthcare providers who need everyday items like dental instruments, medications, vaccines, and office equipment. Henry Schein is one of the largest distributors of healthcare products to office-based practitioners in the world.

The company makes money by selling physical products at a markup and also earns revenue from software, technology services, and equipment financing aimed at healthcare practices. It operates across North America, Europe, and other international markets, generating roughly $12–13 billion in annual revenue. Its main competitive advantage is its large distribution network and deep relationships with small private practices, which are harder for big-box retailers to serve. A key risk is that consolidation among dental and medical practices could reduce the number of independent customers Henry Schein depends on.

Politician Trades

4 trades / 12mo

2 Congressional buys and 2 sells on HSIC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.7% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+16.9% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

17.7%ownership

↓ Declining

Insider ownership declining — could be dilution or selling

Cash Position

Cash flow positive

$157M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Henry Schein is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
31.8%
Modest — 31.8% gross margin
Profit after running costs
Operating Margin
5.8%
Thin — 5.8% operating margin
Return on the money invested
ROCE
11.1%
Below par — 11.1% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+6.5%
Slow sales growth (+6.5% YoY)
Profit growth
EPS YoY
+10.2%
Earnings growing (+10.2% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
174%
Turns 174% of profit into real cash
Spare cash per sale
FCF Margin
4.0%
Thin free cash flow (4.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
1.21
Elevated debt (1.21)
Covers its interest
Interest Cover
4.87x
Adequate interest coverage (4.9x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
24.9x
Growth-priced — P/E 24.9

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+10.1
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (24.9 → 14.8)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial